Barclays Maintains Overweight on JBS, Lowers Price Target to $20
Benzinga Newsdesk 3 months ago
NewsPrice TargetAnalyst Ratings
Barclays analyst Benjamin Theurer maintains JBS (NYSE:JBS) with a Overweight and lowers the price target from $21 to $20.
Barclays analyst Benjamin Theurer maintains JBS (NYSE:JBS) with a Overweight and lowers the price target from $21 to $20.